Aisling Capital Management LP
Top Portfolio Positions
13 positions ·
$476,288,949 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
5,089,611 | $377,954,512 | 79.35% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
1,316,806 | $30,760,588 | 6.46% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
1,555,664 | $25,590,672 | 5.37% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
568,919 | $11,315,798 | 2.38% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
1,018,018 | $9,111,261 | 1.91% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
1,432,336 | $7,920,818 | 1.66% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
77,031 | $3,786,843 | 0.80% | |
| BMEA |
Biomea Fusion, Inc.
Healthcare
|
2,048,757 | $3,134,598 | 0.66% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
325,000 | $2,353,000 | 0.49% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
108,000 | $1,941,840 | 0.41% |
Portfolio Trend
25 quarters · across all stocks
Holdings in OKUR
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $366,832 | 88,607 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $256,960 | 88,607 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $243,669 | 88,607 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $211,770 | 88,607 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $381,010 | 88,607 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $762,020 | 88,607 | Shares | Sole | 2025-02-12 | |
| No 13F history on record for this holder in this stock. | ||||||